The treatment landscape for hemophilia A and B is expanding with strategies and therapies to optimize efficacy, provide durable hemostasis restoration, and improve safety. These contemporary approaches to care have also led to new pathways and assays for clinical and laboratory monitoring.
In this CME Outfitters Webcast, an interdisciplinary faculty, including a renowned patient advocate who has lived with hemophilia for many years, discuss the impact of key advances in treatment and monitoring on quality of care and outcomes. A focused segment on shared decision making (SDM) keeps the conversation grounded in counseling and collaboration and includes both clinician and patient perspectives.
In this recorded CME Outfitters webcast entitled, Finding Balance: Optimizing the Treatment of Patients with Pain, a panel of expert faculty will discuss the 2022 CDC Guideline for Prescribing Opioids for Chronic Pain, changes made since the last Guideline published in 2016, and ways to utilize the new Guideline in the management of pain. Emphasis will be on the need to individualize treatment to the needs of the patient, use of multi-modal pain management strategies, understanding the different pain pathways and biopsychosocial factors individual patients face trying to manage pain.
In this CME Outfitters live webcast, leading clinical experts will help prepare learners to discuss, assess, and address bowel urgency in patients with CD, and will provide insight into the efficacy and safety of new and emerging therapies. The webcast will also include videos capturing the patient journey and first-hand experiences.
In this CME Outfitters livestream symposium, expert faculty will review the role of the IL-23/Th-17 pathway in the pathogenesis of IBD and utilize animated 3-D models to illustrate differences in agents in the anti-IL-23 class that may have potential therapeutic implications. Learners will be guided through an evaluation of the potential clinical implications of CD64 receptor binding by anti-IL-23 mAbs in IBD treatment, as well as the clinical evidence supporting the benefits of these IBD treatment features.
1.5
05/19/2024 at 6:30 pm EST
Angelina E. Collins, MSN, ANP-BC
Angelina E. Collins, MSN, ANP-BC
Edward V. Loftus, Jr., MD
Edward V. Loftus, Jr., MD
Jessica R. Allegretti, MD, MPH, FACG, AGAF
Jessica R. Allegretti, MD, MPH, FACG, AGAF
Miguel Regueiro
Miguel Regueiro earned his bachelor's degree at the University of Pennsylvania, his medical degree at Drexel (Hahnemann) University and completed his internal medicine internship, residency, and clinical and research fellowship training in gastroenterology at Harvard Medical School's Beth Israel Hospital.
Miguel Regueiro
Moderator
Miguel Regueiro earned his bachelor’s degree at the University of Pennsylvania, his medical degree at Drexel (Hahnemann) University and completed his internal medicine internship, residency, and clinical and research fellowship training in gastroenterology at Harvard Medical School’s Beth Israel Hospital.
Dr. Regueiro was Professor of Medicine and Clinical and Translational Science at the University of Pittsburgh School of Medicine from 2000 to 2018. There he served as the IBD Clinical Medical Director, Senior Medical Lead of Specialty Medical Homes, was Professor with Tenure, and honored as the UPMC Endowed Chair for Patient Centered Care in Inflammatory Bowel Diseases.
Dr. Regueiro is currently the Chair of the Department of Gastroenterology and Hepatology and Chair of the Digestive Disease and Surgery Institute at Cleveland Clinic in Ohio. He serves as Medical Co- Chair of Digestive Disease and Surgical Institute Research Governance committee and is Professor of Medicine at the Lerner College of Medicine, Cleveland Clinic.
Dr. Regueiro’s main clinical and research interest is Inflammatory Bowel Diseases with a focus on the natural course of these diseases and postoperative prevention of Crohn’s disease. Recently, he has been involved in transformative medicine initiatives and developing new models of healthcare, including the first-of-its kind specialty medical home for IBD. Dr. Regueiro is investigating alternative models of care in population-based health that integrates patients, payers, providers, pharmaceutical industry, and other facets of healthcare delivery around these novel programs.
In this CME Outfitters livestream symposium, expert faculty will discuss recognizing the frequency of bowel urgency in patients with CD and the impact to patient QoL, incorporating assessments for bowel urgency as part of thorough symptom evaluation for patients with CD, and engaging patients in open communication about their bowel urgency as part of shared decision-making in order to improve clinical outcomes.
1.5
05/20/2024 at 6:15 am EST
Angelina E. Collins, MSN, ANP-BC
Angelina E. Collins, MSN, ANP-BC
Marla Dubinsky, MD
Marla Dubinsky, MD
Moderator
Millie D. Long
Millie D. Long, MD, MPH, is board certified in internal medicine, preventive medicine, and gastroenterology. Dr. Long received her medical degree from University of Virginia in 2002
Millie D. Long
Millie D. Long, MD, MPH, is board certified in internal medicine, preventive medicine, and gastroenterology. Dr. Long received her medical degree from University of Virginia in 2002. She then completed residency in internal medicine and a chief residency at University of Alabama at Birmingham. She completed fellowships in gastroenterology and hepatology, preventive medicine, and inflammatory bowel disease, all at University of North Carolina. She is currently Professor of Medicine in the Department of Medicine and Director of the Gastroenterology and Hepatology Fellowship Program at University of North Carolina at Chapel Hill.
Dr. Long’s clinical practice is at the UNC Multidisciplinary Inflammatory Bowel Diseases (IBD) Center. Her research interests include prevention of complications of IBD, women’s health, and clinical epidemiology. Dr. Long has contributed to over 200 peer-reviewed publications, book chapters, and review articles and to the medical literature. She is the current co-Editor in Chief of the American Journal of Gastroenterology. She also serves as an invited reviewer for journals such as Inflammatory Bowel Diseases and Gastroenterology.
Dr. Long is a fellow of the American College of Gastroenterology, where she serves on the Board of Trustees. She is also a fellow of the American Gastroenterological Association and the Crohn’s and Colitis Foundation, where she co-chairs the Clinical Research Alliance.
In this CMEO Outfitters recorded symposium, expert faculty discuss recognizing the frequency of bowel urgency in patients with CD and the impact on patient QoL, incorporating assessments for bowel urgency through symptom evaluation, and engaging patients in open communication about their bowel urgency as part of shared decision-making in order to improve clinical outcomes, and the faculty also review real-world patient cases.
1.5
02/01/2024
Marla Dubinsky, MD
Marla Dubinsky, MD
Moderator
Tauseef Ali, MD, FACP, FACG, AGAF
Tauseef Ali, MD, FACP, FACG, AGAF
Millie D. Long
Millie D. Long, MD, MPH, is board certified in internal medicine, preventive medicine, and gastroenterology. Dr. Long received her medical degree from University of Virginia in 2002
Millie D. Long
Millie D. Long, MD, MPH, is board certified in internal medicine, preventive medicine, and gastroenterology. Dr. Long received her medical degree from University of Virginia in 2002. She then completed residency in internal medicine and a chief residency at University of Alabama at Birmingham. She completed fellowships in gastroenterology and hepatology, preventive medicine, and inflammatory bowel disease, all at University of North Carolina. She is currently Professor of Medicine in the Department of Medicine and Director of the Gastroenterology and Hepatology Fellowship Program at University of North Carolina at Chapel Hill.
Dr. Long’s clinical practice is at the UNC Multidisciplinary Inflammatory Bowel Diseases (IBD) Center. Her research interests include prevention of complications of IBD, women’s health, and clinical epidemiology. Dr. Long has contributed to over 200 peer-reviewed publications, book chapters, and review articles and to the medical literature. She is the current co-Editor in Chief of the American Journal of Gastroenterology. She also serves as an invited reviewer for journals such as Inflammatory Bowel Diseases and Gastroenterology.
Dr. Long is a fellow of the American College of Gastroenterology, where she serves on the Board of Trustees. She is also a fellow of the American Gastroenterological Association and the Crohn’s and Colitis Foundation, where she co-chairs the Clinical Research Alliance.
Join our newsletter
Stay up to date on new CME Outfitters activities, breaking news, and important developments in medical education.